Background Remote Patient Monitoring (RPM) technologies are changing the way healthcare is delivered, but their particular effects on pharmacy practice, especially in medication management, as well as in pharmacovigilance and clinical decision-making are not sufficiently synthesized. Aim To map and synthesize technological solutions in RPM and assess their potential to assist pharmacist-led medication optimization, safety surveillance, and data-driven virtual care. Method This scoping review was carried out on the basis of the framework offered by Arksey and O’Malley, and it was refined in accordance with the recommendations provided by Joanna Briggs Institute, and reported in line with PRISMA-ScR standards. Literature in English related to the field published since 2010 was searched in five databases (PubMed, Scopus, Web of Science, IEEE Xplore, and Google scholar). Results Out of 1432 records found, 282 were duplicates and 1150 were screened. After conducting full-text evaluation of 150 articles, 48 articles had met inclusion criteria. various reported clinical settings involved in RPM are: multiple setting (n = 28), Home setting (n = 4), remote monitoring programs (n = 1), clinical setting (n = 2), healthcare setting (n = 6), pharmacy setting (n = 4), comprehensive remote monitoring (n = 1), telepharmacy (n = 1), community pharmacy (n = 1). It was found that there are five technological areas, namely, wearable biosensors, Internet of Things connectivity, artificial intelligence and machine learning analytics, cloud computing infrastructures, and telemedicine platforms. All of these technologies facilitated the ability to conduct uninterrupted biometric surveillance, real-time compliance, predictive risk-stratification, therapeutic optimization, and secure data integration and enhance virtual pharmacist-controlled consultations to manage chronic diseases. Conclusion RPM technologies show high prospects in evolving pharmacist-led virtual care and managing pharmacotherapy through precision. The necessary changes to sustainably integrate into any pharmacy practice are creating detailed competency frameworks, enhancing data governance, regulatory clarity, and developing approaches to achieve equitable digital health access.

A scoping review on remote patient monitoring technologies

期刊论文
出版模式：

开放获取
发表日期：

2026年4月4日

查看全文

V. Venkatesan,
Ian Osoro,
M. G. Rajanandh

摘要

Background

Remote Patient Monitoring (RPM) technologies are changing the way healthcare is delivered, but their particular effects on pharmacy practice, especially in medication management, as well as in pharmacovigilance and clinical decision-making are not sufficiently synthesized.

Aim

To map and synthesize technological solutions in RPM and assess their potential to assist pharmacist-led medication optimization, safety surveillance, and data-driven virtual care.

Method

This scoping review was carried out on the basis of the framework offered by Arksey and O’Malley, and it was refined in accordance with the recommendations provided by Joanna Briggs Institute, and reported in line with PRISMA-ScR standards. Literature in English related to the field published since 2010 was searched in five databases (PubMed, Scopus, Web of Science, IEEE Xplore, and Google scholar).

Results

Out of 1432 records found, 282 were duplicates and 1150 were screened. After conducting full-text evaluation of 150 articles, 48 articles had met inclusion criteria. various reported clinical settings involved in RPM are: multiple setting (n = 28), Home setting (n = 4), remote monitoring programs (n = 1), clinical setting (n = 2), healthcare setting (n = 6), pharmacy setting (n = 4), comprehensive remote monitoring (n = 1), telepharmacy (n = 1), community pharmacy (n = 1). It was found that there are five technological areas, namely, wearable biosensors, Internet of Things connectivity, artificial intelligence and machine learning analytics, cloud computing infrastructures, and telemedicine platforms. All of these technologies facilitated the ability to conduct uninterrupted biometric surveillance, real-time compliance, predictive risk-stratification, therapeutic optimization, and secure data integration and enhance virtual pharmacist-controlled consultations to manage chronic diseases.

Conclusion

RPM technologies show high prospects in evolving pharmacist-led virtual care and managing pharmacotherapy through precision. The necessary changes to sustainably integrate into any pharmacy practice are creating detailed competency frameworks, enhancing data governance, regulatory clarity, and developing approaches to achieve equitable digital health access.